Jean Hubble
Adamas Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Botulinum Toxin and Related Neurological Disorders, Nuclear Receptors and Signaling, Genetic Neurodegenerative Diseases
Most-Cited Works
- Pramipexole vs Levodopa as initial treatment for Parkinson disease: A randomized controlled trial(2000)
- → Mitochondrial Polymorphisms Significantly Reduce the Risk of Parkinson Disease(2003)535 cited
- → High‐frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor(1997)482 cited
- → Long-term evaluation of deep brain stimulation of the thalamus(2006)368 cited
- → The effect of deprenyl and levodopa on the progression of Parkinson's disease(1995)335 cited
- → Age at Onset in Two Common Neurodegenerative Diseases Is Genetically Controlled(2002)314 cited
- → Randomized trial of the adenosine A 2A receptor antagonist istradefylline in advanced PD(2003)296 cited